Tscan Therapeutics Inc. (TCRX)

Market is closed

Hedge Fund Popularity

13F filing is ongoing

Hedge Fund Holdings
Filing Period:
Last update:
No. Hedge Fund Shares Value Activity % Port
1. 5,357,347 $7,393,139 2.65%
2. 4,889,474 $6,747,474 +64% 0.28%
3.
Adage Capital Management

Phill Gross And Robert Atchinson

3,500,000 $4,830,000 0.01%
4.
Baker Bros. Advisors

Julian Baker And Felix Baker

2,784,792 $3,843,013 0.04%
5.
Propel Bio Management

Leen Kawas And Richard Kayne

2,087,139 $2,880,252 3.35%
Insider Trading: Purchases See All
Insider Price Amount Total Value Remaining Holdings Date Form 4
$1.20 1,200,000 $1,440,000.00 7,946,141 2025-05-20 Filing
$1.20 1,388,794 $1,666,552.80 6,746,141 2025-05-19 Filing
$2.90 100,000 $290,140.00 5,357,347 2024-12-13 Filing
$3.01 31,800 $95,628.96 5,257,347 2024-12-12 Filing
$4.34 947 $4,113.96 5,225,547 2024-11-15 Filing
Insider Trading: Sales See All
Insider Price Amount Total Value Remaining Holdings Date Form 4
$5.78 164,686 $952,115.64 4,716 2024-08-23 Filing
$2.51 400 $1,003.00 5,224,600 2023-05-31 Filing
$2.52 15,000 $37,801.50 5,225,000 2023-05-31 Filing
$2.51 10,000 $25,148.00 5,240,000 2023-05-31 Filing
Institutional Investors' Holdings
Filing Period:
No. Name Shares Value % Port
1. 4,878,833 $6,732,789 0%
2. 2,356,746 $3,252,310 0%
3. 1,245,504 $1,718,796 0.16%
4. 1,077,080 $1,486,370 0.09%
5. 1,046,916 $1,444,744 0.05%
News See All